Literature DB >> 12668877

Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Nithya Krishnan1, Huiqi Pan, Donna J Buckley, Arthur Buckley.   

Abstract

Previously we showed that the distal element (DE) (-427 to -336 bp) within the pim-1 promoter appeared to regulate its prolactin (PRL)-induced transcription. To determine which specific DE sequences conferred PRL responsiveness, seven 12-bp deletion mutants ligated upstream of the chloramphenicol acetyltransferase gene were transfected into FDC/Nb2 cells. Results from promoter/ reporter studies showed that sequential 12-bp deletions of the DE significantly (p < 0.001) reduced PRL responsiveness. An additional site, nuclear factor-1 (-224 to -217), was also mutated by deletion or point mutation; both abrogated promoter activation by PRL (p < 0.0001). In other experiments, PRL signaling to pim-1 expression was investigated in FDC/Nb2 cells stably expressing the wild-type (WT) Jak2 cDNA or a carboxy-terminal kinase-deficient Jak2 mutant and in cells infected with adenoviral constructs of WT-Akt or dominant negative Akt. Altered Jak2 did not affect PRL-stimulated pim-1 expression while inhibition of Akt attenuated its transcription. We conclude that the DE and NF-1 half-site mediate PRL responsiveness of the pim-1 promoter. Moreover, the accumulated evidence does not support a role for the Jak2/Stat signaling pathway but, instead, implicates that Akt activation was a component of PRL-induced pim-1 transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668877     DOI: 10.1385/endo:20:1-2:123

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  71 in total

1.  The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells.

Authors:  I Sakai; A S Kraft
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  MEBA derepresses the proximal myelin basic protein promoter in oligodendrocytes.

Authors:  C Taveggia; A Pizzagalli; M L Feltri; J B Grinspan; J Kamholz; L Wrabetz
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

3.  The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter.

Authors:  T C Meeker; J Loeb; M Ayres; W Sellers
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  The rat growth hormone and human cellular retinol binding protein 1 genes share homologous NF1-like binding sites that exert either positive or negative influences on gene expression in vitro.

Authors:  S Leclerc; W Eskild; S L Guérin
Journal:  DNA Cell Biol       Date:  1997-08       Impact factor: 3.311

5.  Prolactin regulation of pim-1 expression: positive and negative promoter elements.

Authors:  K E Borg; M Zhang; D Hegge; R L Stephen; D J Buckley; N S Magnuson; A R Buckley
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

6.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Recombinant human pim-1 protein exhibits serine/threonine kinase activity.

Authors:  D Hoover; M Friedmann; R Reeves; N S Magnuson
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

8.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

9.  Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin.

Authors:  C V Clevenger; D H Russell; P M Appasamy; M B Prystowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor.

Authors:  M T Yip-Schneider; M Horie; H E Broxmeyer
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  11 in total

Review 1.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 3.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

Review 4.  Breast Cancer and Prolactin - New Mechanisms and Models.

Authors:  Charles V Clevenger; Hallgeir Rui
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

5.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

6.  Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC).

Authors:  Yi Jin; Da-Yue Tong; Lu-Ying Tang; Jian-Ning Chen; Jing Zhou; Zhi-Ying Feng; Chun-Kui Shao
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

Review 7.  Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte.

Authors:  Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-08

8.  Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.

Authors:  Dig B Mahat; Sarah E Brennan-Laun; Elizabeth J Fialcowitz-White; Aparna Kishor; Christina R Ross; Tatyana Pozharskaya; J David Rawn; Perry J Blackshear; Bret A Hassel; Gerald M Wilson
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

9.  PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells.

Authors:  Carolin Seifert; Ellen Balz; Susann Herzog; Anna Korolev; Sebastian Gaßmann; Heiko Paland; Matthias A Fink; Markus Grube; Sascha Marx; Gabriele Jedlitschky; Mladen V Tzvetkov; Bernhard H Rauch; Henry W S Schroeder; Sandra Bien-Möller
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

10.  Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.

Authors:  Yi Jin; Da-yue Tong; Jian-ning Chen; Zhi-ying Feng; Jian-yong Yang; Chun-kui Shao; Jia-ping Li
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.